Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Consensus Rating of “Moderate Buy” by Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $22.2727.

A number of brokerages have recently commented on SBRA. Robert W. Baird lifted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a research note on Wednesday, July 22nd. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Finally, Barclays initiated coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 target price on the stock.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $20.61 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. Sabra Healthcare REIT has a 52 week low of $17.17 and a 52 week high of $22.77. The stock has a market capitalization of $5.27 billion, a price-to-earnings ratio of 79.27, a PEG ratio of 1.57 and a beta of 0.64. The stock has a fifty day moving average of $20.43 and a 200-day moving average of $20.16.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm had revenue of $230.11 million for the quarter, compared to the consensus estimate of $219.39 million. During the same quarter in the prior year, the firm earned $0.38 EPS. The company’s revenue was up 24.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 461.54%.

Institutional Trading of Sabra Healthcare REIT

Several institutional investors have recently modified their holdings of SBRA. PNC Financial Services Group Inc. grew its stake in Sabra Healthcare REIT by 2.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock worth $451,000 after purchasing an additional 528 shares during the period. Larson Financial Group LLC lifted its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the period. Inspire Investing LLC boosted its holdings in shares of Sabra Healthcare REIT by 2.3% during the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after buying an additional 565 shares in the last quarter. Nissay Asset Management Corp Japan boosted its holdings in shares of Sabra Healthcare REIT by 1.5% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock worth $760,000 after buying an additional 585 shares in the last quarter. Finally, Natixis Advisors LLC boosted its holdings in shares of Sabra Healthcare REIT by 2.2% during the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after buying an additional 598 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.